Recombinant UPF0256 protein SAV_5428 (SAV_5428)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
SAV_5428; Uncharacterized N-acetyltransferase SAV_5428; EC 2.3.1.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-409
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)
Target Names
SAV_5428
Target Protein Sequence
MTTDVRVLRQ DDWNLWYDTL IRAFGGVAEA SEERELWQTL TECDRSIGVW DGDACVGTAG AFSFRVTVPG GASVPAAGIT MVSVAATHRR RGVLTAMMRR QLDDIRSWGE PLAVLTASEP AIYGRFGYGI GTHQLTADVD TSRVRLSVPP GTDDVRLRYA VPADVLDVCE AVYARLVPGR PGMPARRPGW DRLMVLDPES RRDGASPLQC VVAERDGETV GYTRFRVKPD WEPSGPKGTV VLQDLEALDP AAHAALWRFL FDIDLTSHLN ARNRPLDEAW LHLVSDIRRC NLRKRDSLHV RLVDVGAALE ARTYQAPVDV VFEVEDAFCP WNEGRWRLTG DGKGATCVRT RDSVDLALSV RDLGAAYLGG VSLVSLGAAG RVRELRPGAL TEATSAFSSA IAPWLPHGF
Uniprot No.

Q&A

What are the optimal host systems for expressing recombinant UPF0256 protein SAV_5428?

E. coli and yeast expression systems provide the optimal balance of yield and production time for recombinant UPF0256 protein SAV_5428. These prokaryotic and lower eukaryotic systems offer high protein yields with relatively straightforward protocols and shorter turnaround times compared to more complex expression systems .

For researchers prioritizing production efficiency:

Host SystemYield EfficiencyTurnaround TimeComplexityCost
E. coliHighShortLowLow
YeastHighShort-MediumMediumMedium
Insect cellsMediumMedium-LongHighHigh
Mammalian cellsLow-MediumLongVery HighVery High

When native protein folding and post-translational modifications are critical for experimental objectives, insect cells with baculovirus or mammalian expression systems should be considered despite their lower yields and longer production times .

How can electroporation be optimized for delivering recombinant proteins like UPF0256 protein SAV_5428 into mammalian cells?

Electroporation represents an efficient method for delivering defined amounts of recombinant proteins into cultured mammalian cells. For optimal electroporation of recombinant proteins like UPF0256 protein SAV_5428, researchers should follow these methodological guidelines:

  • Concentration Optimization: Intracellular uptake scales linearly with input concentrations, allowing for precise control of protein delivery .

  • Cell Recovery Period: Allow at least four hours post-electroporation for cell recovery and re-establishment of normal physiology and morphology .

  • Cell-Type Considerations: Electroporation protocols can be adapted across multiple cell lines with limited toxicity when optimized .

  • Multi-Protein Delivery: Co-delivery of multiple labeled proteins (e.g., with CFP, TAMRA) is feasible for interaction studies .

Researchers should conduct preliminary experiments with fluorescently-labeled UPF0256 protein SAV_5428 to determine optimal electroporation parameters for their specific cell types and experimental objectives.

What experimental design approaches can optimize soluble expression of recombinant UPF0256 protein SAV_5428?

Implementing factorial experimental design offers a systematic approach for optimizing soluble expression of recombinant proteins like UPF0256 protein SAV_5428. Based on methodologies employed for other recombinant proteins, researchers should:

  • Identify Critical Variables: The eight key variables that significantly impact soluble protein expression include:

    • IPTG concentration

    • Induction temperature

    • Induction duration

    • Harvest optical density (OD600)

    • Media composition factors (yeast extract concentration, tryptone concentration, salt concentration, glucose concentration)

  • Apply Statistical Analysis: Implement factorial design (such as 2^8-4 design) to efficiently evaluate variable combinations with minimal experimental runs .

  • Validate Optimized Conditions: Once statistical analysis identifies optimal conditions, validate through triplicate experiments. For similar recombinant proteins, optimal conditions typically include:

ParameterOptimized Value
Induction OD6000.8
IPTG Concentration0.1 mM
Induction Temperature25°C
Induction Duration4 hours
Media Composition5 g/L yeast extract, 5 g/L tryptone, 10 g/L NaCl, 1 g/L glucose
Antibiotic30 μg/mL kanamycin

This methodological approach has demonstrated the ability to achieve high-level soluble expression (up to 250 mg/L) of functional recombinant proteins with approximately 75% homogeneity .

How can researchers assess and quantify UPF0256 protein SAV_5428 abundance in cellular systems?

Accurate quantification of protein abundance provides critical insights into protein function and regulation. For UPF0256 protein SAV_5428 abundance studies, researchers should implement:

  • Normalization Protocols: Convert abundance measurements to standard units (molecules per cell) to enable cross-study comparisons .

  • Multiple Measurement Approaches: Combine complementary quantification methods:

    • Mass spectrometry-based quantification

    • Western blotting with calibrated standards

    • Fluorescence-based quantification (if using tagged variants)

  • Data Integration Framework: Follow protocols similar to those used by the Saccharomyces Genome Database (SGD) to normalize different datasets:

    • Evaluate data from multiple studies

    • Convert to common measurement units

    • Calculate median abundance values

    • Determine median absolute deviation for statistical robustness

  • Environmental Response Analysis: Compare abundance values between standard conditions and environmental stressors to elucidate regulatory mechanisms .

For comprehensive abundance analysis, researchers should develop a sortable database similar to the SGD model, incorporating metadata and environmental conditions to facilitate deeper understanding of UPF0256 protein SAV_5428 regulation.

What methodologies are recommended for investigating the in vivo function of UPF0256 protein SAV_5428?

For comprehensive functional characterization of UPF0256 protein SAV_5428, researchers should implement a multi-faceted approach:

  • Fluorescent Labeling Strategy: Generate versions of UPF0256 protein SAV_5428 with:

    • Genetically encoded fluorescent tags (CFP, GFP)

    • Synthetic dye labeling (TAMRA, Atto488)

    • Site-specific labeling using Sortase-ligation method

  • Electroporation Delivery: Utilize electroporation for controlled delivery of labeled protein to:

    • Track subcellular localization

    • Monitor protein dynamics

    • Identify interaction partners

  • Complementation Assays: For definitive functional validation:

    • Deplete endogenous protein using RNAi

    • Electroporate recombinant protein

    • Assess restoration of function

    • Verify uptake by western blotting

  • Co-Delivery Studies: Electroporate multiple labeled proteins simultaneously to study:

    • Complex formation

    • Protein-protein interactions

    • Sequential binding events

This methodological framework allows researchers to progress beyond static structural studies to dynamic functional characterization of UPF0256 protein SAV_5428 in living cells.

How can post-translational modifications of UPF0256 protein SAV_5428 be preserved and studied?

Post-translational modifications (PTMs) often critically influence protein function and regulation. For UPF0256 protein SAV_5428, researchers should consider:

  • Expression System Selection: While E. coli and yeast provide higher yields, they offer limited PTM capabilities. For studying PTMs:

    • Insect cell expression with baculovirus enables many eukaryotic modifications

    • Mammalian cell expression provides the most physiologically relevant PTMs

  • Modification-Specific Methods:

    • For studying farnesylation (similar to Spindly protein), researchers can:

      • Express protein in cells with inhibited farnesyltransferase

      • Perform in vitro farnesylation of purified protein

      • Electroporate the modified protein back into cells

  • Validation Approaches:

    • Mass spectrometry to identify and quantify specific modifications

    • Site-directed mutagenesis of modification sites to confirm functional relevance

    • Comparative functional assays between modified and unmodified forms

This integrated approach allows researchers to preserve and functionally characterize post-translational modifications that may be essential for UPF0256 protein SAV_5428 activity.

What strategies can address poor solubility of recombinant UPF0256 protein SAV_5428 during expression?

Poor solubility represents a common challenge in recombinant protein expression. For UPF0256 protein SAV_5428, implement these methodological solutions:

  • Temperature Optimization: Lowering induction temperature to 25°C can significantly improve protein folding and solubility compared to standard 37°C protocols .

  • Media Reformulation: Consider the following adjustments:

    • Reduce glucose concentration to 1 g/L to limit metabolic stress

    • Balance nitrogen sources (5 g/L yeast extract, 5 g/L tryptone)

    • Maintain moderate salt concentration (10 g/L NaCl)

  • Induction Parameters:

    • Use lower IPTG concentrations (0.1 mM) to reduce expression rate

    • Induce at mid-log phase (OD600 of 0.8) rather than early or late growth phases

    • Limit induction time to 4 hours to prevent inclusion body formation

  • Fusion Partners: Consider expressing UPF0256 protein SAV_5428 with solubility-enhancing fusion partners:

Fusion TagSize (kDa)Solubility EnhancementPurification Method
MBP42.5HighAmylose resin
GST26MediumGlutathione resin
SUMO11.5HighNi-NTA + protease
Thioredoxin11.7Medium-HighVarious methods

These strategies, particularly when guided by factorial experimental design approaches, can address solubility challenges systematically rather than through trial-and-error .

How can researchers troubleshoot electroporation challenges when delivering UPF0256 protein SAV_5428 into cells?

Electroporation delivery offers many advantages but requires troubleshooting specific challenges:

  • Cell Viability Concerns:

    • Problem: Excessive cell death following electroporation

    • Solution: Implement proper post-EP recovery period (minimum 4 hours) to restore normal cell physiology and morphology

    • Assessment: Monitor cell morphology and viability markers before proceeding with experiments

  • Protein Aggregation Issues:

    • Problem: Protein precipitation during electroporation preparation

    • Solution: Optimize buffer conditions (consider adding glycerol or non-ionic detergents)

    • Validation: Verify protein remains soluble using dynamic light scattering before electroporation

  • Uneven Cellular Uptake:

    • Problem: Heterogeneous protein distribution across cell population

    • Solution: Calibrate input concentration, as uptake scales linearly with concentration

    • Analysis: Use flow cytometry to quantify distribution of fluorescently-labeled protein

  • Functional Activity Loss:

    • Problem: Delivered protein lacks expected activity

    • Solution: Validate protein function before electroporation and optimize buffer conditions

    • Control: Perform activity assays on purified protein pre- and post-electroporation preparation

For comprehensive troubleshooting, researchers should incorporate appropriate controls and systematically evaluate each variable in the electroporation workflow.

How should researchers standardize and compare UPF0256 protein SAV_5428 abundance data across different studies?

To establish meaningful comparisons of UPF0256 protein SAV_5428 abundance data from different studies, researchers should implement standardization protocols:

  • Unit Conversion Methodology: Convert all abundance measurements to molecules per cell to provide a universal reference point across studies .

  • Normalization Process:

    • Identify baseline conditions across studies (e.g., untreated cells in rich media)

    • Calculate conversion factors between different measurement systems

    • Apply statistical methods to account for methodological differences

  • Metadata Integration: Record essential experimental variables:

    • Growth conditions (media composition, temperature)

    • Cell type/strain

    • Growth phase at harvest

    • Measurement methodology

  • Statistical Approach:

    • Calculate median abundance values across normalized datasets

    • Determine median absolute deviation as a measure of variability

    • Apply appropriate statistical tests when comparing abundance under different conditions

This standardization framework enables researchers to meaningfully integrate UPF0256 protein SAV_5428 abundance data across independent studies, revealing consistent patterns in protein regulation and function.

What bioinformatic approaches can predict functional domains and interaction partners of UPF0256 protein SAV_5428?

For comprehensive bioinformatic characterization of UPF0256 protein SAV_5428, researchers should implement:

  • Sequence Analysis Pipeline:

    • Multiple sequence alignments to identify conserved regions

    • Domain prediction through comparison with established protein families

    • Secondary structure prediction to identify potential functional elements

  • Interaction Network Mapping:

    • Integrate protein abundance data with interaction databases

    • Apply co-expression analysis across different conditions

    • Implement computational docking to predict binding partners

  • Functional Annotation Strategy:

    • Gene Ontology term enrichment analysis for predicted interactors

    • Pathway analysis to place UPF0256 protein SAV_5428 in cellular context

    • Cross-species conservation analysis to infer evolutionary significance

  • Experimental Validation Approach:

    • Design experiments to confirm key predictions

    • Prioritize testing interactions with highest confidence scores

    • Use electroporation co-delivery for direct interaction studies

By combining these computational approaches with targeted experimental validation, researchers can generate testable hypotheses about UPF0256 protein SAV_5428 function, even when starting with limited functional information.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.